Insilico Medicine vs Isomorphic Labs
A side-by-side comparison of Insilico Medicine and Isomorphic Labs, two Science tools, drawn from Ignaite's continuously-verified listings.
Compared from listings verified as of
Insilico Medicine
ScienceGenerative AI drug discovery — the end-to-end Pharma.ai suite.
View Insilico MedicineAt a glance
| Attribute | Insilico Medicine | Isomorphic Labs |
|---|---|---|
| Category | Science | Science |
| Pricing | PAID | PAID |
| License | Proprietary | Proprietary |
| Deployment | Cloud | Cloud |
| Platforms (differs) | Web, API | Web |
| Model support (differs) | Self-contained (on-device) | — |
| Vendor (differs) | Insilico Medicine | Isomorphic Labs |
The honest brief
Insilico Medicine
Sells its full discovery pipeline as licensed software — pharma can run PandaOmics and Chemistry42 directly, not just via a partner-only program.
- End-to-end Pharma.ai software suite
- Used by most of the top-20 pharma
- First AI-designed drug into Phase 2
- $2.75B Eli Lilly partnership
- Enterprise-only, opaque pricing
- Built for pharma R&D, not general users
- No approved drug yet
- Heavy domain expertise required
Isomorphic Labs
Direct lineage to Nobel-winning AlphaFold plus Alphabet backing — few AI-drug shops pair that model pedigree with deep-pocket pharma partnerships.
- AlphaFold-derived design models
- Alphabet-backed capital
- Top-pharma partnerships
- Nobel-laureate leadership
- Pharma partnerships only
- No public product or API
- No approved drug yet
- Opaque pricing